Long-Term Halo Follow-Up Confirms Less Invasive Treatment of Low-Grade Cartilaginous Tumors with Radiofrequency Ablation to Be Safe and Effective.
Hendricus NijlandJelle OverboschJoris J W PloegmakersThomas C KweePaul Christiaan JuttePublished in: Journal of clinical medicine (2021)
RFA is a safe and effective treatment in low-grade cartilaginous tumors with an initial success rate of 89.0%. Extended follow-up shows no local recurrences and gradual substitution of the halo with normal bone.